Abstract
The standard of care treatment for locally advanced rectal cancer is neoadjuvant chemoradiation followed by total mesorectal excision. In recent years, organ-sparing treatments, instead of standard total mesorectal excision, are gradually introduced in the treatment of rectal cancer for patients with good response after neoadjuvant therapy. However, patient selection for
... read more